189 related articles for article (PubMed ID: 11486902)
1. Factor V Leiden mutation in Turkish patients with homozygous cystathionine beta-synthase deficiency.
Kalkanoğlu HS; Coşkun T; Aydoğdu SD; Tokatli A; Gürgey A
J Inherit Metab Dis; 2001 Jun; 24(3):367-9. PubMed ID: 11486902
[TBL] [Abstract][Full Text] [Related]
2. Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis.
Mandel H; Brenner B; Berant M; Rosenberg N; Lanir N; Jakobs C; Fowler B; Seligsohn U
N Engl J Med; 1996 Mar; 334(12):763-8. PubMed ID: 8592550
[TBL] [Abstract][Full Text] [Related]
3. Homozygous cystathionine beta-synthase deficiency, combined with factor V Leiden or thermolabile methylenetetrahydrofolate reductase in the risk of venous thrombosis.
Kluijtmans LA; Boers GH; Verbruggen B; Trijbels FJ; Novakova IR; Blom HJ
Blood; 1998 Mar; 91(6):2015-8. PubMed ID: 9490685
[TBL] [Abstract][Full Text] [Related]
4. Factor V Leiden (Arg506Gln), a confounding genetic risk factor but not mandatory for the occurrence of venous thromboembolism in homozygotes and obligate heterozygotes for cystathionine beta-synthase deficiency.
Yap S; O'Donnell KA; O'Neill C; Mayne PD; Thornton P; Naughten E
Thromb Haemost; 1999 Apr; 81(4):502-5. PubMed ID: 10235428
[TBL] [Abstract][Full Text] [Related]
5. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of cerebral venous sinus thrombosis (CVST) as presentation of cystathionine beta-synthase deficiency in childhood: molecular and clinical findings of Turkish probands.
Karaca M; Hismi B; Ozgul RK; Karaca S; Yilmaz DY; Coskun T; Sivri HS; Tokatli A; Dursun A
Gene; 2014 Jan; 534(2):197-203. PubMed ID: 24211323
[TBL] [Abstract][Full Text] [Related]
7. The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.
Martinelli I; Bucciarelli P; Margaglione M; De Stefano V; Castaman G; Mannucci PM
Br J Haematol; 2000 Dec; 111(4):1223-9. PubMed ID: 11167765
[TBL] [Abstract][Full Text] [Related]
8. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.
Kader HA; Berman WF; Al-Seraihy AS; Ware RE; Ulshen MH; Treem WR
J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):629-35. PubMed ID: 12454577
[TBL] [Abstract][Full Text] [Related]
10. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A
Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
[TBL] [Abstract][Full Text] [Related]
11. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
[TBL] [Abstract][Full Text] [Related]
12. Two common genetic thrombotic risk factors: factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis.
Gurgey A; Haznedaroglu IC; Egesel T; Buyukasik Y; Ozcebe OI; Sayinalp N; Dundar SV; Bayraktar Y
Am J Hematol; 2001 Jun; 67(2):107-11. PubMed ID: 11343382
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
Nishank SS; Singh MP; Yadav R
Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
[TBL] [Abstract][Full Text] [Related]
14. Association of the prothrombin G20210A mutation with factor V Leiden in a midwestern American population.
Bavikatty NR; Killeen AA; Akel N; Normolle D; Schmaier AH
Am J Clin Pathol; 2000 Aug; 114(2):272-5. PubMed ID: 10941343
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
[TBL] [Abstract][Full Text] [Related]
16. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
17. Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis.
Kurkowska-Jastrzebska I; Wicha W; Dowzenko A; Vertun-Baranowska B; Pytlewski A; Bogusławska R; Członkowska A
Med Sci Monit; 2003 May; 9(5):CS41-5. PubMed ID: 12761462
[TBL] [Abstract][Full Text] [Related]
18. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
[TBL] [Abstract][Full Text] [Related]
19. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N
Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]